NCT00346164 · OUTCOME

Percent Tumor Necrosis

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: MEAN
Unit: percentage of tumor necrosis
Interval / dispersion: Standard Deviation
Time frame: 13 weeks

What was measured

Percent tumor necrosis by pathology review.

Analysis population: Only Arm D patients were evaluated at week 13 for percent tumor necrosis. Ineligible and inevaluable Arm D patients were excluded.

Groups in this outcome

Arm D

Intermediate \& High Risk; Neoadjuvant chemoradiotherapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Arm D	129

Reported measurements

Source class 1

Values in percentage of tumor necrosis · Interval/dispersion: Standard Deviation
Group	Value	Spread	Lower	Upper	Comment
Arm D	59.4	38.5	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
spread
38.5
value
59.4

denoms

counts
group Id
OG000
value
129
units
Participants

description

Percent tumor necrosis by pathology review.

dispersion Type

Standard Deviation

groups

description
Intermediate \& High Risk; Neoadjuvant chemoradiotherapy
id
OG000
title
Arm D

param Type

MEAN

population Description

Only Arm D patients were evaluated at week 13 for percent tumor necrosis. Ineligible and inevaluable Arm D patients were excluded.

reporting Status

POSTED

time Frame

13 weeks

title

Percent Tumor Necrosis

type

SECONDARY

unit Of Measure

percentage of tumor necrosis

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice